Skip to main content

Table 2 Future clinical implications of molecular genetic findings in fibromyalgia

From: Developments in the scientific and clinical understanding of fibromyalgia

Subgrouping of fibromyalgia patients
Pharmacologic treatment based on knowledge of patient's genotype
• Subjects with the short 5-HTTLPR allele may be more suitable candidates for antidepressant medication
• Subjects without the 7DRD4 allele may be candidates for dopaminergic medication